These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9391779)

  • 21. Management of bone loss in inflammatory bowel disease.
    Lichtenstein GR
    Semin Gastrointest Dis; 2001 Oct; 12(4):275-83. PubMed ID: 11726081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Osteoporosis associated with inflammatory bowel diseases].
    Miheller P; Tóth M; Pregun I; Tulassay Z
    Orv Hetil; 2004 May; 145(20):1045-51. PubMed ID: 15202326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory bowel disease and the risk of osteoporosis and fracture.
    Targownik LE; Bernstein CN; Leslie WD
    Maturitas; 2013 Dec; 76(4):315-9. PubMed ID: 24139749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis.
    Goodhand JR; Kamperidis N; Nguyen H; Wahed M; Rampton DS
    Aliment Pharmacol Ther; 2011 Mar; 33(5):551-8. PubMed ID: 21198706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride.
    Abitbol V; Mary JY; Roux C; Soulé JC; Belaiche J; Dupas JL; Gendre JP; Lerebours E; Chaussade S;
    Aliment Pharmacol Ther; 2002 May; 16(5):919-27. PubMed ID: 11966500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid-induced osteoporosis.
    Reid IR
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Jun; 14(2):279-98. PubMed ID: 11035907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D screening by gastroenterologists in patients with inflammatory bowel disease.
    Bakshi A; Nguyen H; Borum M
    Am J Gastroenterol; 2009 Mar; 104(3):791. PubMed ID: 19262531
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.
    Kenanidis E; Potoupnis ME; Kakoulidis P; Leonidou A; Sakellariou GT; Sayegh FE; Tsiridis E
    Expert Opin Drug Saf; 2015 Jul; 14(7):1035-53. PubMed ID: 25952267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mineral density in patients with inflammatory bowel disease from north-eastern Romania.
    Dumitrescu G; Mihai C; Dranga M; Prelipcean CC
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):23-8. PubMed ID: 24505888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review.
    Melek J; Sakuraba A
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):32-44.e5. PubMed ID: 23981521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
    Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
    Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoid-induced osteoporosis in inflammatory bowel disease.
    Lidofsky S; Smith J
    Med Health R I; 2009 Apr; 92(4):128-30. PubMed ID: 19452756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation and treatment of osteoporosis in patients with fragility fractures.
    Hajcsar EE; Hawker G; Bogoch ER
    CMAJ; 2000 Oct; 163(7):819-22. PubMed ID: 11033708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases.
    Gluck O; Colice G
    Chest; 2004 May; 125(5):1859-76. PubMed ID: 15136401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency, risk factors, and adverse sequelae of bone loss in patients with ostomy for inflammatory bowel diseases.
    Gupta S; Wu X; Moore T; Shen B
    Inflamm Bowel Dis; 2014 Feb; 20(2):259-64. PubMed ID: 24378598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and treatment of osteoporosis in inflammatory bowel disease.
    Lichtenstein GR; Sands BE; Pazianas M
    Inflamm Bowel Dis; 2006 Aug; 12(8):797-813. PubMed ID: 16917235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.